Abstract
Lipopolysaccharide (LPS) is a compound macromolecule anchored in the outer leaflet of the outer membrane of Gram-negative bacteria (Fig. 1) and extending out from the cell into the external medium (for detailed reviews see Jann and Jann 1984; MäKELä and Stocker 1984). It is a major structural component of the cell surface, and it has been calculated that there are about 2.5 × 106 molecules per cell in Salmonella typhimurium, occupying some 45% of the surface of the outer membrane (Inouye 1979). Each LPS molecule is composed of three distinct structural segments, namely the innermost hydrophobic lipid A moiety, which constitutes the main lipid component of the outer leaflet of the asymmetrical outer membrane; the outermost O-specific polysaccharide (also called the O-antigen or somatic antigen), which consists of a short orlong linear polymer of an oligosaccharide repeat unit; and the core oligosaccharide, which links the O-antigen to the lipid A. LPS molecules interact structurally and functionally with a number of other cell surface components, including several outer membrane proteins (LUGTENBREG and van Alphen 1983; Nikaido and Vaara 1985).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Attridge SR, Daniels D, Morona JK, Morona R (1990) Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210. Microb Pathoge 8: 177–188
Austin EA, Graves JF, Hite LA, Parker CT, Schnaitman CA (1990) Genetic analysis of lipopolysaccharide core biosynthesis by Escherichia coli K-12: Insertion mutagenesis of the rfa locus. J Bacteriol 172: 5312–5325
Baron LS, Kopecko DJ, Formal SB, Seid R, Guerry P, Powell C (1987) Introduction of Shigella flexneri 2a Type and group antigen genes into oral typhoid vaccine strain Salmonella typhi Ty21a. Infect Immun 55: 2797–2801
Beutler B, Cerami A (1988) The history, properties, and biological effects of Cachetin. Biochemistry 27: 7575–7582
Binns MM, Vaughan S, Timmis KN (1985) ‘O’-antigens are essential virulence factors of Shigella sonnei and Shigella dysenteriae. Zentralbl Balzteriol Miknrbiol Hyg [B] 181:197–205
Brahmbhatt HN, Quigley NB, Reeves PR (1986) Cloning part of the region encoding biosynthetic enzymes for surface (O-antigen) of Salmonella typhimurium. Mol Gen Genet 203:172–176
Brahmbhatt HN, Wyk PJ, Quigley NB, Reeves PR (1988) A complete physical map of the rfb locus encoding biosynthetic enzymes for the O-antigen of Salmonella typhimurium LT2. J Bacteriol 170:98–102
Buchanan TM, Pearce WA (1979) Pathogenic aspects of outer membrane components of Gram-negative bacteria. In: Inouye M (ed) Bacterial outer membranes. Wiley, New York, pp 475–514
Charles I, Dougan G (1990) Gene expression and the development of live enteric vaccines. Trends Biochem 8: 117–121
Devino LV (1959) The specific prophylaxis of dysentery with vaccines from complete antigens. Zh Miobiol Epidemiol Immunobiol 30: 22–31
Dupont HL, Hornick RB, Snyder MJ, Libonati JL, Formal SB, Gangarosa EJ (1972) Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis 125: 12–16
Ewing WH, Lindberg AA (1984) Serology of Shigella. In: Bergan T (ed) Methods in Microbiology, vol 14. Academic, London, pp 113–142
Falkone G, Campa M, Smith H, Scott GM (1984) Bacterial and viral inhibition and modulation of host defences. Academic, London Farrar WE (1985) Antibiotic resistance in developing countries. J Infect Dis 152: 1103–1107
Fontaine A, Arondel J, Sansonetti PJ (1990) Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1. Res Microbiol 141: 907–912
Formal SB, Levine MM (1984) Shigellosis. In: Germanier R (ed) Bacterial vaccines. Academic, New York, pp 167–186
Formal SB, LaBrec EH, Palmer A, Falkow S (1965) Protection of monkeys against experimental shigellosis with attenuated vaccines. J Bacteriol 90: 63–68
Formal SB, Kent TH, Austin S, LaBrec EH (1966a) Fluorescent-antibody and histological study of vaccinated and control monkeys challenged withShigella flexneri. J Bacteriol 91: 2368–2376
Formal SB, Kent TH, May HC, Palmer A, Falkow S, LaBrec EH (1966b) Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J Bacteriol 92: 17–22
Formal SB, Maenza RM, Austin S, LaBrec EH (1967) Failure of parenteral vaccines to protect monkeys against experimental shigellosis. Proc Soc Exp Biol Med 25: 347–349
Formal SB, Gemski P, Baron LS, LaBrec EH (1970) Genetic transfer of Shigella flexneri 2a antigens to Escherichia coli K-12. Infect Immun 1: 279–287
Formal SB, Baron LS, Kopecko DJ, Washington O, Powell C, Life CA (1981) Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun 34: 746–750
Formal SB, Hale TL, Kapfer C, Cogan JP, Snoy PJ, Chung R, Wingfield ME, Elisberg BL, Baron LS (1984) Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen. Infect Immun 46: 465–469
Gamian A, Romanowska E (1982) The core structure of Shigella sonnei lipopolysaccharide and the linkage between O-specific polysaccharide and the core region. Eur J Biochem 129: 105–109
Gemski P Jr, Formal SB (1975) Shigellosis: an invasive infection of the gastrointestinal tract. In: Schlessinger D (ed) American Society for Microbiology, Washington, DC, pp 165–169
Gemski P Jr, Stocker BAD (1967) Transduction by bacteriophage P22 in nonsmooth mutants of Salmonella typhimurium. J Bacteriol 93:1588–1597
Gemski P Jr, Sheahan DG, Washington O, Formal SB (1972) Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens. Infect Immun 6:104–111
Gemski P Jr, Koeltzow DE, Formal SB (1975) Phage conversion of Shigella flexneri group antigens. Infect Immun 11: 685–691
Godard C, Hannecart-Pokorni E (1977) Étude d’un locus génétique rfa impliqué dans la biosynthése du ‘core’ du lipopolyoside de la paroi Shigella flexneri F6S. Ann Inst Pasteur Microbiol 128A: 19–33
Goldman RC, Joiner K, Leive L (1984) Serum-resistant mutants of Escherichia coli 0111 contain increased lipopolysaccharide, lack an O-antigen-containing capsule, and cover more of their lipid A core with O antigen. J Bacteriol 159: 877–882
Grossman N, Leive L (1984) Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length. J Immunol 132: 376–385
Hale TL (1990) Hybrid vaccines using Escherichia coli as an antigen carrier. Res Microbiol 141:913–919
Hale TL, Formal SB (1989) Oral Shigella vaccines. Curr Top Microbiol Immunol 146: 205–211
Hale TL, Formal SB (1990) Live oral vaccines consisting of Escherichia coli orSalmonella typhi expressing Shigella antigens. In: Woodrow GC, Levine MM (eds) New generation vaccines. Marcel Dekker, New York, pp 667–677
Hale TL, Sansoneetti PJ, Schad A, Austin S, Formal SB (1983) Characterization of virulence plasmids and plasmid associated outer membrane proteins inShigella flexneri, Shigella sonnei, and Escherichia coli. Infect Immun 40: 340–350
Hale TL, Guerry P, Seid RC, Kapfer C, Wingfield ME, Reaves CB, Baron LS, Formal SB (1984) Expression of lipopolysaccharide O-antigen inEscherichia coli K-12 hybrids containing plasmid and-chromosomal genes from Shigella dysenteriae 1. Infect Immun 46: 470–475
Hannecart-Pokomi E, Godard C, Beumer J (1976) Chimiotypes de mutants R de Shigella flexneri et récepteurs de phages. 1. Etude chimique des lipopolyosides. Ann Microbiol 127B: 3–14
Herrero M, Lorenzo VD, Timmis KN (1990) Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria. J Bacteriol 172: 6557–6567
Higgins AR, Floyd TM, Kader MA (1955) Studies in shigellosis III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment. Am J Trop Med Hyg 4: 281 -284
Inouya M (1979) What is the outer membrane? In: Inouya M (ed) Bacterial outer membranes. Wiley, New York, pp 1–12
Iseki S, Hamano S (1959) Conversion of type antigen IV in Shigella flexneri by bacteriophage. Proc Jpn Acad 35: 407–412
Izhar M, Nuchamowitz Y, Mirelman D (1982) Adherence of Shigella flexneri to guinea pig intestinal cells is mediated by mucosal adhesin. Infect Immun 35: 1110–1118
Jann K, Jann B (1984) Structure and biosynthesis of O-antigens. In: Rietschel ET (ed) Chemistry of endotoxin, pp 138–186, Handbook of endotoxin, vol. 1. Elsevier, Amsterdam
Jann K, Westphal 0 (1975) Microbial polysaccharides. In: Sela M (ed) The antigens. Academic, New York, 3: 1–125
Jansson PE, Lindberg AA, Lindberg B, Wollin R (1981) Structural studies on the hexose region of the core in lipopolysaccharides from enterobacteriaceae. Eur J Biochem 115: 571–577
Jiang XM, Neal B, Santiago F, Lee SJ, Romana LK, Reeves PR (1991) Structure and sequence of the rfb (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Mol Miocrobiol 5: 695–713
Joiner KA, Schmetz MA, Goldman RC, Leive L, Frank MM (1984) Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli 0111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. Infect Immun 45: 113–117
Joiner KA, Grossman N, Schmetz M, Leive L (1986) C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol 136: 710–715
Kadis S, Weinbaum G, Ajl SJ (1971) Microbial toxins, vol 5. Academic, New York
Kauffmann F (1961) Die Bakteriologie der Salmonella Species. Munksgaard, Copenhagen
Kauffmann F (1966) The bacteriology of enterobacteriaceae. Munksgaard, Copenhagen, pp 76–80
Kenne L, Lindberg B (1983) Bacterial polysaccharides. In: Aspinall GO (ed) The polysaccharides, vol. 2. Academic, New York, pp 287–363 (Molecular biology series)
Ketyl I, Rauss K, Vertenyl A (1974) Oral immunization against dysentery. Acta Microbiol Acad Sei Hung 21:81–85
Keusch GT, Bennish ML (1988) Shigellosis. In: Evans AS, Brachman P (eds) Bacterial diseases of humans. Plenum, New York
Kiener PA, Marek F, Rodgers G, Lin PF, Warr G, Desiderio J (1988) Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A.J. Immunol 141: 870–874
Kopecko DJ, Washington O, Formal SB (1980) Genetic and physical evidence för plasmid control of Shigella sonnei form I cell surface antigen. Infect Immun 29: 207–214
Levine MM (1982) Bacillary dysentery. Mechanisms and treatment. Med Clin North Am 66: 623
Liang-Takasaki CJ, Mäkelä PH, Leive L (1982) Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol 128: 1229–1235
Lindberg AA (1973) Bacteriophage receptors. Annu Rev Microbiol 27: 205–237
Lindberg AA, Karnell A, Stocker BAD, Katakura S, Sweiha H, Reinholt FP (1988) Development of an auxotrophic oral live Shigella flexneri vaccine. Vaccine 6:147–150
Lindberg B, Lonngren J, Romanowska E, Rüden U (1972) Location of O-acetyl groups in Shigella flexneri types 3c and 4b lipopolysaccharides. Acta Chem Scand 26: 3808–3810
Linde K, Dentchev V, Bondarenko V (1990) Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication. Vaccine 8: 25–29
Loppnow H, Brade H, Dürrbaum I, Dinarello CA, Kusumoto S (1989) IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 142: 3229–3238
Lüderitz O, Westphal O, Staub AM, Nikaido H (1971) Isolation and chemical and immunological characterization of bacterial lipopolysaccharides. In: Weinbaum G, Kadis S, Ajl SJ (eds) Microbial toxins, vol 4. Academic, New York, pp 145–233
Lugtenberg B, van Alphen L (1983) Molecular architecture and functioning of the outer membrane of Escherichia coli and other Gram-negative bacteria. Biochem Biophys Acta 737: 51–115
Maagd RAD, Lugtenberg BJJ (1987) Outer membranes of Gram-negative bacteria. Biochem Soc Trans 15 [Suppl] 54–62
Mäkelä P, Stocker BAD (1984) Genetics of lipopolysaccharide. In: Rietschel ET (ed) Chemistry of endotoxin. Elsevier, Amsterdam, pp 59–136 (Handbook of endotoxin, vol 1)
Mäkelä P, Bradley DJ, Brandis H, Frank MM, Hahn H, Henkel W, Jann K, Morse SA, Robbins RB, Rosenstreich DL, Smith H, Timmis K, Tomasz A, Turner MJ, Wiley DS (1980) Evasion of host defences. In: Smith H, Skehel JJ, Turner MJ (eds) The molecular basis of microbial pathogenicity. Verlag Chemie, Weinheim, pp 175–198
Matsui S (1958) Antigenic changes in the Shigella flexneri group by bacteriophage. Jpn J Microbiol 2: 153–158
McGrath BC, Osborn MJ (1991) Localization of the terminal steps of O-antigen synthesis in Salmonella typhimurium. J Bacteriol 173: 649–654
Mel DM, Terzin AL, Vuksic L (1965a) Studies on vaccination against bacillary dysentery. I. Immunization of mice against experimentalShigella infection. Bull WHO 32: 633–636
Mel DM, Terzin AL, Vuksic L (1965b) Studies on vaccination against bacillary dysentery. Ill, Effective oral immunization againstShigella flexneri 2a in a field trial. Bull WHO 32: 647–655
Mel DM, Gangarosa EJ, Radovanovic ML, Arsic BL, Litoinjenko S (1971) Studies on bacillary dysentery. Bull WHO 45: 457–464
Mills SD, Timmis KN (1988) Genetics of O-antigen polysaccharide biosynthesis in Shigella and vaccine development. In: Cabello FC, Pruzzo C (eds) Bacteria, complement and the phagocytic cell. Springer, Berlin Heidelberg New York, pp 21–39
Mills SD, Sekizaki T, Gonazalez-Carrero MI, Timmis KN (1988) Analysis and genetic manipulation of Shigella virulence determinants for vaccine development. Vaccine 6:116–122
Mims CA (1982) The pathogenesis of infectious disease, 2nd edn. Academic, London
Nikaido H, Vaara M (1985) Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49: 1–32
Nurminen M, Wahlström E, Kleemola M, Leinonen M, Saikku P, Mäkela, H (1984) Immunologically related ketodeoxyoctonate-containing structures in Chlamydia trachomatis, Re mutants of Salmonella species, and Acinetobacter calcoaceticus var. anitratus. Infect Immun 44: 609- 613
Okada N, Sasakawa C, Tobe T, Yamada M, Nagai S, Talukder KA, Komatsu K, Kanegasaki S, Yoshikawa M (1991) Virulence-associated chromosomal loci of Shigella flexneri identified by random Tn5 insertion mutagenesis. Mol Microbiol 5:187–195
Okamura N, Nakaya R (1977) Rough mutants of Shigella flexneri 2a that penetrate tissue culture cells but does not evoke keratoconjunctivitis in guinea pigs. Infect Immun 17: 4–8
Okamura N, Nagei T, Nakaya R, Kondo S, Murakami M, Hisatsune K (1983) HeLa cell invasiveness and O antigen of Shigella flexneri as separate and prerequisite attributes of virulence to evoke keratoconjunctivitis in guinea pigs. Infect Immun 39: 505–513
Pegues JC, Chen L, Gordon AW, Ding GL, Coleman WG Jr (1990) Cloning, expression, and characterization of theEscherichia coli K-12rfaü gene. J Bacteriol 172: 4652–4660
Penn CW (1983) Bacterial envelope and humoral defences. In: Easmon CSF, Jeljaszewicz J, Brown MRW, Lambert PA (eds) Role of the envelope in the survival of bacteria in infection. Academic, London, pp 109–135 (Medical microbiology, vol 3)
Pluschke G, Mayden J, Achtman M, Levine RP (1983) Role of the capsule and the O antigen in resistance of 018: K1 Escherichia coli to complement-mediated killing. Infect Immun 42:907- 913
Popoff. MY, Le Minor L (1985) Expression of antigenic factor 054 is associated with the presence of a plasmid inSalmonella. Ann Inst Pasteur Microbiol [B] 136:169–179
Raetz CRH (1990) Biochemistry of endotoxins. Annu Rev Biochem 59:129–170
Reske K, Jann K (1972) The 08 antigen of Escherichia coli. Structure of the polysaccharide chain. Eur J Biochem 67: 320–328
Riley LW, Junio LN, Libaek LB, Schoolnik GK (1987) Plasmid-encoded expression of lipopolysaccharide O-antigenic polysaccharide in enteropathogenicEscherichia coli. Infect Immun 55: 2052–2056
Riley LW, Junio LN, Schoolnik GK (1990) HeLa cell invasion by a strain of enteropathogenic Escherichia coli that lacks the O-antigenic polysaccharide. Mol Microbiol 4: 1661–1666
Robbins PW, Wright A (1971) Biosynthesis of O-antigens. In: Weinbaum G, Kadis, S, Ajl SJ (eds) Microbial toxins vol 4. Academic, New York, pp 351–368
Robbins PW, Wright A, Dankert M (1966) Polysaccharide biosynthesis. J Gen Physiol 49: 331–346
Romanowska E, Reinhold V (1973) 2-Amino-2-deoxyhexuronic acid: a constituent of Shigella sonnei phase I lipopolysaccharide. Eur J Biochem 36: 160–166
Sansonetti PJ, Arondel J (1989) Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis. Vaccine 7: 443–450
Sansonetti P, David M, Toucas M (1980) Correlation entre la perte d’ADN plasmidique et le passage de la phase I virulente ä la phase II avirulente chez Shigella sonnei. C R Acad Sci 290: 879–882
Sansonetti P, Formal SB, Hale TL, Kopecko DJ (1981a) Bases genetique de la penetration de Shigella flexneri dans les cellules epitheliales. Ann Immunol 132:183–189
Sansonetti P, Kopecko DJ, Formal SB (1981b) Shigella sonnei plasmids: evidence that a large plasmid is necessary for virulence. Infect Immun 34: 75–83
Sansonetti PJ, Hale TL, Dammin GJ, Kapfer C, Collins HH Jr, Formal SB (1983) Alterations in the pathogenesis of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri. Infect Immun 34:1392–1402
Scid RC, Kopecko DJ, Sadoff JC, Schneider H, Baron LS, Formal SB (1984) Unusual lipopolysaccharide antigens of Salmonella typhi and vaccine strain expressing the Shigella sonnei form I antigen. J Biol Chem 259: 9028–9034
Simmons DAR (1971) Immunochemistry of Shigella flexneri O-antigens: a study of structural and genetic aspects of the biosynthesis of cell-surface antigens. Bacteriol Rev 35:117–148
Sturm S, Timmis KN (1986) Cloning of the rfb gene region of Shigella dysenteriae 1 and construction of an rfb-rfp gene cassette for the development of lipopolysaccharide-based live anti-dysentery vaccines. Microb Pathog 1: 289–297
Sturm S, Fortnagel P, Timmis KN (1984) Immunoblotting procedure for the analysis of electrophoretically fractionated bacterial lipopolysaccharides. Arch Microbiol 140:198–201
Sturm S, Jann B, Jann K, Fortnagel P, Timmis KN (1986a) Genetic and biochemical analysis of Shigella dysenteriae 1 O antigen polysaccharide biosynthesis inEscherichia coli K-12: 9 kb plasmid of S. dysenteriae 1 determines addition of a galactose residue to the lipopolysaccharide core. Microb Pathog 1: 299–306
Timakov VD, Petrovskava VG, Bondarenko VM (1970) Studies of the genetic control of Shigella subgroup B type specific antigens. Ann Inst Pasteur 118: 3–9
Timmis KN, Boulonois GJ, Bitter-Suermann D, Cabello FC (1985) Surface components of Escherichia coli that mediate resistance to bactericidal activities of serum and phagocytosis. Curr Top Microbiol Immunol 118: 197–218
Timmis KN, Gonzalez-Carrero MI, Sekizaki T, Rojo F (1986a) Biological activities specified by antibiotic resistance plasmids. J Antimicrob Chemother 18 (Suppl. C): 1–12
Timmis KN, Sturm S, Watanabe H (1986b) Genetic dissection of pathogenesis determinants of Shigella and enteroinvasiveEscherichia coli. In: Holmgren J, Lindberg AA, Möllby R (eds) Development of vaccines and drugs against diarrhoea. Student Literatur, Lund, pp 107- 126
Verma NK, Reeves PR (1989) Identification and sequence of rfbS and rfbE, which determine antigenic specificity of group A and group D salmonellae. J Bacteriol 171: 5694–5701
Verma NK, Quigley NB, Reeves PR (1988) O-antigen variation inSalmonella spp.: rfb gene clusters of three strains. J Bacteriol 170:103–107
Watanabe H, Timmis KN (1984) A small plasmid in Shigella dysenteriae 1 specifies one or more functions essential for O antigen production and bacterial virulence. Infect Immun 43: 391–396
Watanabe H-, Nakamura A, Timmis KN (1984) Small virulence plasmid ofShigella dysenteriae 1 strain W30864 encodes a 41,000-dalton protein involved in formation of specific lipopolysaccharide side chains of serotype 1 isolates. Infect Immun 46: 55–63
Westphal O, Jann K, Himmelspach K (1983) Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog Allergy 33: 9–39
H. N. Brahmbhatt et al.: Shigella Lipopolysaccharide
Wollenweber H-W, Rietschel ET (1990) Analysis of lipopolysaccharide (lipid A) fatty acids. J Microbiol Methods 11:195–211
Wölpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG (1988) Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 167: 570–581
Wyk P, Reeves PR (1989) Identification and sequence of the gene for abequose synthetase, which confers antigenic specificity on group B salmonellae: homology with galactose epimerase. J Bacterid 171: 5687–5693
Yoshida Y, Okamura N, Kato J, Watanabe H (1991) Molecular cloning and characterization of form I antigen genes of Shigella sonnei. J Gen Microbiol 137: 867–874
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Brahmbhatt, H.N., Lindberg, A.A., Timmis, K.N. (1992). Shigella Lipopolysaccharide: Structure, Genetics, and Vaccine Development. In: Sansonetti, P.J. (eds) Pathogenesis of Shigellosis. Current Topics in Microbiology and Immunology, vol 180. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77238-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-77238-2_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77240-5
Online ISBN: 978-3-642-77238-2
eBook Packages: Springer Book Archive